SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-21-000171
Filing Date
2021-06-21
Accepted
2021-06-21 15:08:15
Documents
80
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 10-Q gnbt043021form10q.htm 10-Q 1330483
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 11913
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11883
4 EXHIBIT 32 ex32.htm EX-32 3831
11 GRAPHIC image_001.gif GRAPHIC 3785
  Complete submission text file 0001607062-21-000171.txt   5568959

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20210430.xml EX-101.INS 763135
6 XBRL SCHEMA FILE gnbt-20210430.xsd EX-101.SCH 72115
7 XBRL CALCULATION FILE gnbt-20210430_cal.xml EX-101.CAL 71147
8 XBRL DEFINITION FILE gnbt-20210430_def.xml EX-101.DEF 263740
9 XBRL LABEL FILE gnbt-20210430_lab.xml EX-101.LAB 404072
10 XBRL PRESENTATION FILE gnbt-20210430_pre.xml EX-101.PRE 367428
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 211030131
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences